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A B S T R A C T
Introduction: The new concept of separation surgery has changed the surgical paradigms for the treatment of
metastatic epidural spinal cord compression (MESCC), shifting from aggressive cytoreductive surgery towards
less invasive surgery with the aim to achieve circumferential separation of the spinal cord and create a safe target
for high dose Stereotactic Body Radiation Therapy (SBRT), which turned out to be the real game-changer for
disease’s local control.
Discussion: In this review a qualitative analysis of the English literature has been performed according to the
rating of evidence, with the aim to underline the increasingly role of the concept of separation surgery in MESCC
treatment. A review of the main steps in the evolution of both radiotherapy and surgery fields have been de-
scribed, highlighting the important results deriving from their integration.
Conclusion: Compared with more aggressive surgical approaches, the concept of separation surgery together
with the advancements of radiotherapy and the use of SBRT for the treatment of MESCC showed promising
results in order to achieve a valuable local control while reducing surgical related morbidities and complications.
1. Introduction
Spinal metastases are considered one of the most relevant health
burdens in oncological care, with a prevalence of approximately
30–40% among patient suffering from cancer [1–6]. Metastatic Epi-
dural Spinal Cord Compression (MESCC) occurs in 10% of cases, with
its related high risk of neurological impairments and disability [7,8].
In recent years, significant development in radiological diagnostic
tools and new oncological treatments have radically changed life ex-
pectancy in metastatic patients [9–11] and consequentially the man-
agement of spinal cord metastases. Specifically, a longer survival of
metastatic patients supported the possibility to prescribe ablative
treatments as an emerging oncological strategy, also in spine metas-
tases. Moreover, technological improvements in Radiation Oncology
field allowed a dose painting to the target and a sparing of normal
tissues. In this scenario, Stereotactic Radiosurgery (SRS) or Stereotactic
Body Radiation Therapy (SBRT) are emerging treatment for spinal
metastases in order to obtain greater local control (LC) than conven-
tional External Beam Radiation Therapy (cEBRT) [12–19].
Considering the systemic nature of MESCC, surgical treatment plays
a functional role in preserving or restoring neurological status and
spinal stability [6,16,20]. With the introduction of ablative radiation
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treatment (SRS or SBRT) in the new paradigms of treatment [16],
surgery for decompression in MESCC has evolved, shifting from ag-
gressive cytoreduction, in order to obtain neurological outcomes im-
provement and better LC, towards the modern idea of “separation
surgery”(SS) [7].
Separation surgery represents an innovative and promising way to
improve tumor resection and therefore offer the possibility of per-
forming adequate radiation therapy. The circumferential decompres-
sion of the spinal cord/nerve roots is useful not only in order to pre-
serve or restore neurological functions, but also to create - above all - an
ablative target for SRS. This technique creates a safe distance between
the tumor and the spinal cord, allowing the delivery of ablative doses
on target lesion [13,21–23]. The achievement of a proper decompres-
sion of the cord, even with Minimally Invasive Surgical (MIS) techni-
ques, in order to ensure safe high-dose SRS or SBRT, eventually com-
bined with systemic treatment, has become the new target in high
volume centers with availability of SRS [2,7,21,22,24,25].
According to these new concepts, MESCC treatment should need
could not ignore anymore the need for a multidisciplinary management
involving spine surgeons, radiation oncologists and oncologists
[16,26–29]. The aim of this review is to describe the State of the Art
about the concept of SS in its surgical and clinical aspects, while ex-
amining the medical evidence published on this topic.
2. Methods
Selection criteria and references for this review were identified by
searching PubMed using the terms “separation surgery”, “metastatic
epidural compression”, “separation surgery AND spinal metastases”,
“separation surgery AND epidural spinal compression” and “separation
surgery AND metastatic epidural compression”. Only articles published
in English, until May 10, 2020 were reviewed. Inclusion criteria of the
references were based on the scope of this review, according to PRISMA
(Preferred Reporting Items for Systematic Reviews and Meta-analysis)
guidelines [30]. A total number of 174 articles were found, but only 48
of them were considered to be relevant after thorough evaluation
(Fig. 1). Hence, each article was classified according to its evidence rate
using the Sacket Grading System [31]. Some studies did not satisfy the
grading system, which resulted not applicable in those cases (Table 1).
3. Background
The first step of in the management of patients with MESCC should
be represented by a comprehensive assessment in order to evaluate of
the performance status, patient’s eligibility for surgery and/or radio-
therapy, and a global prognostic estimation when achievable
[3,13,22,29]. Karnofsky Performance Status (KPS) and Eastern Co-
operative Oncology Group Performance Status Scale (ECOG PS) are the
most useful scores to assess patient’s functional status [32,33].
Throughout the years, many prognostic scoring systems have been de-
veloped in order to helping decision making. Tomita and Tokuhashi
scores [34,35] have represented real cornerstones for surgeons, but
have become progressively out of date because the stability assessment
and the impact of new advancements in from radiotherapy/radio-
surgery and systemic treatment targeted therapy/immunotherapy were
not considered [3,22,36]. Furthermore, the decision making was based
only on survival prognostic factors. Gasbarrini et al. proposed a mul-
tidisciplinary algorithm for the treatment of spinal metastases focusing
on functional status (neurology and stability of the spine), considering
the ASA score for the surgical eligibility and oncological (chemotherapy
and radiotherapy) treatments available [26].
In 2013 Laufer et al. proposed the Neurologic, Oncologic,
Mechanical Instability and Systemic Disease (NOMS) framework that
introduced a dynamic and updated model for decision making and
patients selection. Moreover, oncological assessment is predicted taking
into account the tumor histotype and its known responses obtained
with the current treatment modalities (chemotherapy, immunotherapy,
biologic therapy, hormones, cEBRT, SBRT and SRS) thus, overcoming
the technological related bias that affected the previous scores [16].
Systemic assessment was mainly influenced by patient’s co-morbidities
Fig. 1. PRISMA Flow Chart.
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and performance status. Neurological and spinal stability evaluations
were considered the most important aspects in order to define surgical
indications [3,16].
Neurological assessment reflected the degree of Epidural Spinal
Cord Compression (ESCC), evaluated with the ESCC scale (Bilsky Scale)
(Table2), and the presence or absence of myelopathy and / or radicu-
lopathy due to neural foramen collapse [16,37]. The ESCC scale is used
to discern the absence (Grade 0) or minimal epidural compression
(Grade 1a, 1b, 1c) from high grade epidural compression (Grade 2 or 3)
[3,37]. Mechanical instability assessment was performed using the
Spinal Instability Neoplastic Score (SINS) system by Fisher et al.
(Table 3), in order to recognize patients with potential or overt spinal
instability (values> 6) and to provide the best treatment [38]. Me-
chanical pain, indeed, typically related to the patient’s movements and
resulting from an unstable spine, usually requires surgical treatment
since it could not be treated with radiotherapy or chemotherapy
[2,3,7,22,39].
Hence, once assessed neurology and spinal instability, another es-
sential issue is represented by primitive tumor radio-sensitiveness [3].
Myeloma, lymphoma, and seminoma in particular, but also breast
tumor [40], prostate tumor and ovarian tumor have been traditionally
considered radiosensitive tumors: in these cases, cEBRT showed to be
effective in inducing a local cytoreduction [3,16,41–44]. On the other
hand, renal, thyroid, hepatocellular, colon, sarcoma, melanoma and
non small cell lung cancer (NSCLC) represented a group of neoplasms
less radiosensitive. characterized by high resistance to cERBT [45,46].
During the last decade, the concept of radio-resistance in oncological
spine has been overcome with the introduction of SRS and SBRT. In
2008 Yamada et al. published the first series of patients treated with
single fraction SRS (dose range 18–24 Gy), showing a recurrence rate
and local control consistently improved in comparison with cERBT,
Table 1
Reviewed articles and evidence rate according to Sacket Grading System [31].
Study Number Reference Type of Study Evidence Rate [31]
1 Moussazadeh et al, 2014 [6] Review 3
2 Spratt et al, 2017 [7] Review 3
3 Katsoulakis et al, 2017 [15] Review 3
4 Amankulor et al, 2013 [88] Retrospective cohort study 2
5 Barzilai et al, 2018 [86] Prospective cohort study 2
6 Joaquim et al, 2015 [3] Review 3
7 Tatsui et al, 2016 [100] Prospective cohort study 2
8 Tseng et al, 2017 [13] Review 3
9 Thind et al, 2017 [89] Case series 4
10 Zhou et al, 2019 [67] Retrospective cohort study 3
11 Husain et al, 2017 [29] Review 3
12 Di Martino et al, 2016 [69] Review 3
13 Laufer et al, 2013 [12] Retrospective outcome study 2
14 Caruso et al, 2015 [11] Review 3
15 Bate et al, 2015 [66] Retrospective cohort study 3
16 Bilsky et al, 2014 [73] Review 3
17 Komagata et al, 2004 [74] Case report N/A
18 Tatsui et al, 2015 [99] Case series 4
19 Xiaozhou et al, 2019 [67] Prospective outcome study 1
20 Cofano et al, 2019 [81] Case series 4
21 Conti et al, 2019 [36] Review 3
22 Barzilai et al, 2017 [39] Prospective cohort study 2
23 Barzilai et al, 2018 [2] Expert opinion 5
24 Rothrock et al, 2020 [22] Expert opinion 5
25 Drakhshandeh et al, 2018 [87] Pro/Retrospecitve cohort study 2/3
26 Zuckerman et al, 2016 [76] Review 3
27 Hadzipasic et al, 2020 [101] Case report N/A
28 Hu et al, 2020 [8] Retrospective outcome/cohort study 2/3
29 Meleis et al, 2019 [63] Retrospective outcome study 2
30 Alghamdi et al, 2019 [14] Retrospective cohort study 3
31 Kelly et al, 2019 [62] Review 2/3
32 Vega et al, 2019 [75] Expert opinion 5
33 Turel et al, 2017 [104 [ Case series 4
34 Fanous et al, 2017 [49] Review 3
35 Greenwood et al, 2015 [93] Retrospective cohort study 3
36 Jandial et al, 2013 [85] Retrospective cohort study 3
37 Fridley et al, 2017 [48] Review 3
38 Delgado-Lopez et al, 2019 [25] Review 3
39 De Almeida Bastos et al, 2020 [98] Prospective cohort study 2
40 Davarski et al 2013 [84] Retrospective cohort study 3
41 Ghogawala et al, 2001 [54] Retrospective cohort study 3
42 Rades et al, 2011 [46] Retrospective outcome/cohort study 2/3
43 Anand et al, 2015 [65] Prospective cohort study 2
44 Miller et al, 200083 Retrospective outcome study 2
45 Vega et al, 2020 [94] Review 3
46 Ho et al, 2016 [55] Retrospective outcome study 2
Table 2
Bilsky’s Epidural Spinal Cord Compression (ESCC) grading system37.
Grade Description
Low Grade 0 Bone only disease
1 a Epidural impingement, without deformation of thecal sac
1 b Deformation of the thecal sac, without spinal cord abutment
1 c Deformation of the thecal sac, with spinal cord abutment,
without cord compression
High Grade 2 Spinal cord compression, with cerebrospinal fluid (CSF)
visible around the cord
3 Spinal cord compression, no CSF leak visible around the cord
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regardless of tumor histology and volume [17,19]. The only limit of SRS
is represented by the need to create a safe distance between the tumor
and the spinal cord, which is indeed the aim of SS in high grade ESCC
[16,22,47–50]. Recently, Cofano et al. proposed the Neurologic Stabi-
lity Epidural compression (NSE) score with the aim to translate all these
concepts in a practical score evaluating the need for surgery in patients
with MESCC, according to the latest evidence and assessing ASA, per-
formance status, neurological status, spine stability and ESCC [28]. In
the setting of a more comprehensive approach with SRS as a new and
relevant treatment option, SS has carved out a key role in MESCC
treatment, creating the adequate conditions for radiations
[2,6,7,12,20,22,26].
4. Evolutions in radiotherapy
4.1. Conventional external beam radiation therapy
Many studies analyzed effectiveness of cEBRT both as primary and
adjuvant treatment for MESCC. Historically, cERBT with palliative in-
tent (30 Gy in 10 fractions, 20 Gy in 5 fractions or 8 Gy in one fraction)
have been considered the main treatment options for spinal metastases
[20]. In a recent review, Barzilai et al. underlined the wide range of
response duration and recurrence rate after adjuvant cERBT and its
strong dependency from tumor histology of primary tumor, with poorly
responses in radioresistant tumors [36,42,51]. Pain relief, neurological
status and LC were the outcomes analyzed in different series [42].
Maranzano et al. reported approximately 60% of pain relief with
median duration of less than 4 months (LC at 2 years: 30%) in radio-
resistant tumors, with better results among patients suffering from
radiosensitive tumors (LC at 2 years: 86%) [51]. In a meta-analysis of
25 RCTs, Chow et al. reported lower recurrence pain rates (8% vs 20%)
and lower complications rate for patients receiving fractionated treat-
ment compared to single fraction group [52]. In a subset analysis of
Radiation Therapy Oncology Group (RTOG) trial 97–14 by Howell et al,
reported less acute toxicity for 8 Gy/1 fraction, but with a higher rate of
re-treatment than 30 Gy/10 fractions. The two schedules of treatment
resulted in comparable pain relief and narcotic use at 3 months.
Lastly, a randomized study by Rades et al. compared administration
of 20 Gy/5 fractions and 30 Gy/10 fractions in a cohort of 203 patients
with poor life expectancy and motor deficits of the lower extremities,
reporting no differences in 1-month overall motor response between the
two groups; therefore, short-course fractionation schedule could be
considered in these selected cases [52].
4.2. SBRT and SRS
SRS and SBRT could be considered the real “game changer” in the
paradigm of MESCC treatment [20,29,53–55].
These techniques allow the delivery of high total dose in a single or
few fraction (s) to small target volumes, minimizing the dose exposure
of normal tissue [13]. As Katsulakis et al. reported in their review, the
possibilities to create steep dose gradients around the spinal cord,
minimizing dose to the nearby structures (e.g. spine, nerve roots, eso-
phagus), while delivering ablative radiation doses to the tumor, re-
presented the real introduced novelty [15]. Typically, SRS is delivered
in a single treatment, whereas SBRT is delivered as two to five treat-
ments [7]. The high doses of radiations induce tumour cell killing
through a direct tumoricidal effect and promote different cellular
apoptosis pathways activation, resulting in a strong ablative effect [7].
Many studies have analyzed SBRT or SRS with or without surgery,
but the retrospective analysis by Laufer et al. is still considered the
landmark study in this field [7,12,13,15,22,23,56,57]. They reported
results from 186 patients who underwent surgery and SRS treatment
with different regimens [12]. Firstly, the treatment efficacy was in-
dependent from the tumor histotype, as already observed in the
aforementioned study by Yamada et al.[17,18]. Then, they found that
radiation dose was the only factor significantly associated with tumor
progression; lower recurrence rates were reported in patients treated
with high-dose hypo-fractionated SRS (median total dose 27 Gy in 3
fractions) or single fraction SRS (24 Gy) compared to patients who
underwent low-dose hypo-fractionated SRS (median total dose 30 Gy in
5 or 6 fractions) (Recurrence rate: 4.1%, 9%, 22% respectively) [12].
Al-Omair et al. emphasized the importance of epidural decompres-
sion, reporting outcomes in 80 patients undergoing post-surgical SBRT
with 1-year LC of 84%. Interestingly, epidural space was the most
common site of recurrence (66% of recurrences) and multivariate
analysis showed that epidural residual was the only factor significantly
related to LC rate [58]. Recently, Redmond et al. reported results from
the first prospective study analyzing post-operative SBRT (30 Gy in 5
fractions), showing 1-year LC of 91.4% [59]. Notably, Ito et al. ana-
lyzed a retrospective series of 28 patients previously treated with
cEBRT, who underwent surgery and subsequent re-irradiation with
SBRT (24 Gy in 2 fractions), reporting 1-year LC of 70%, showing SBRT
feasibility even for re-irradiation [60].
Nevertheless, although many subsequent studies have reported
comparable outcomes, the first prospective trial with the aim to com-
pare outcomes of cEBRT (8 Gy in a single fraction) versus radiosurgery
(16 Gy or 18 Gy in a single fraction) is still ongoing (ClinicalTrials.gov
NLM Identifier: NCT02512965) [13,61].
However, contouring guidelines, treatment schedules and compli-
cations represented the most interesting debatable issues [8,56,62–65].
Bate et al. reported a series of 57 patients showing the efficacy of SBRT
and SRS both with and without surgery. Remarkably, they found higher
LC rate in single fraction RT group, but it was not statistically sig-
nificant [66]. Moreover, recent series reported cumulative 1-year local
failure related to epidural grade and association between LC and
Table 3
SINS score. Recommendation TS >= 7: Consider surgical intervention.
Component Score
Location
Junctional (O-C2; C7-T2; T11-L1; L5-S1) 3
















> 50% collapse 3
< 50% collapse 2
No collapse with > 50% body involved 1




None of the above 0
Criteria of instability
Total score (TS) 0–6 Stable
Total score (TS) 7–11 Potential unstable
Total score (TS) 12–18 Unstable
* Pain improvement with recumbency and/or pain with movement/loading
of the spine.
± Facet, pedicle, joint fracture or replacement with tumor [38].
G. Di Perna, et al. Journal of Bone Oncology 25 (2020) 100320
4
epidural disease downgrading, pain relief rate of 88.5% and association
between SRS and overall survival [14,67]. Associations with overall
survival could be related to the synergistic effects between ablative
radiotherapy treatment and systemic treatment, also known as abscopal
effect, recently investigated by Caruso at al. in patients with metastatic
spinal melanoma [11].
Vertebral compressive fractures (VCF) and radiation myelopathy
were considered the main complications of SRS/SBRT [7,13,22,56]. A
systematic review by Chang et al. reported the incidence of VCF ranging
from 0.7% to 40.5%, variable with different schedules [56]. Although
radiation myelopathy was reported especially in the first series, maybe
due to the initial lack of understanding the tolerance of the spinal cord
(now assessed to 14–16 Gy) [64], it should be considered a rare com-
plication and should not be a contraindication for treatment [56].
Consensus guidelines by Redmond et al., provided the best indications
to obtain the higher ablative effect with the lesser risk of complications
[64] (Table 4).
On one hand, SBRT introduction has radically refocused the radia-
tion therapy’s goal, from the simple pain relief towards the more at-
tractive attempt to achieve LC, overcoming the concept of radio-re-
sistance. On the other hand, this new option in the radiation therapy
armamentarium has led to the innovative concept of hybrid therapy,
shifting the paradigm of MESCC surgery from extended cytoreductive
surgery to effective separation surgery in order to create a target
avoiding damages to the spinal cord.
5. Evolution in surgery
Different surgical approaches and strategies to treat MESCC were
adopted through the years, with the aim to decompress neural struc-
tures and to restore spinal stability, in order to obtain palliative pain
relief and neurological preservation [24,29]. Siegal et al. analyzed the
ability to walk in 78 patients suffering from MESCC and who underwent
different type of surgical decompression (anterior decompression vs
laminectomy). In the anterior decompression group 28% of patients
were ambulatory before surgery and then, 80% were ambulatory after
surgery. Among patients who underwent laminectomy 8% were am-
bulatory before surgery and 39% after surgery [68]. In a systematic
review by Di Martino et al., recommendations in favor to early surgical
treatment (within 48 h) of MESCC were reported [69].
The first study that have substantially changed the role of surgery in
this field was the randomized prospective trial by Patchell et al. that
analyzed the ability to walk among patients undergoing decompressive
surgery and radiation and those treated with radiation alone (radiation
was 30 Gy / 10 fractions in both groups) [7,13,20,22,29,70]. Patients in
the surgical arm showed significative higher rate of ability to walk
compared to patients treated with cERBT alone (84% vs 57%, Odds
Ratio 6.2, p 0.001). Moreover, even secondary endpoints such as ur-
inary continence, pain relief, using of opioid analgesics and steroids,
resulted to be improved into the surgical group [70,71].
More recently, Fehlings et al. showed significant improvements both
in clinical outcomes (ability to walk and pain relief) and patient’s
quality of life (QoL) among patients that underwent surgery and ra-
diation, compared to patients belonging at radiation only group [72].
Nevertheless, as reported by Rothrock et al., these relevant studies
did not consider a longitudinal follow up regarding LC; this could be
considered a major limitation, probably due to the fact that at the time
LC analysis was not a priority since median survival was often less than
a year [22].
Nowadays, indeed, while the role of surgery in achieving neurologic
improvement and stability is clearly defined, the possibility of durable
symptoms palliation with cERBT is still debatable for MESCC in radio-
resistant tumors. Moreover, the newest systemic agents have sig-
nificantly improved the overall survival for the majority of tumor his-
totypes, making durable LC a new goal of this combined strategy [22].
5.1. Separation surgery – surgical technique
The term separation surgery was coined by Lyliana Angelov and
Edward Benzel to designate a procedure in which the goal of surgical
resection was to decompress the spinal cord and provide a safe target
for SRS or SBRT [7]. This term has really changed the surgeons’ idea of
decompressive surgery in MESCC. The durable and reliable LC rates
provided by cERBT in MESCC in radiosensitive tumors and by SRS or
SBRT in MESCC in radio resistant tumors, have questioned the need for
extensive and aggressive cytoreductive surgery [6,20]. Nowadays, ag-
gressive tumor resection (en bloc vertebrectomy or extended intrale-
sional removal of the vertebral body) has lost its role and many authors
suggest to perform this strategy only in selected cases, such as selected
single metastatic spine lesion from radiosensitive tumors, or in cases of
MESCC due to radioresistant tumors in contexts where SRS or SBRT are
not fully available [20,26]. Bilsky et al. suggested aggressive surgery for
superior sulcus lung tumors involving vertebral bodies since they are
usually complicated by the the use of neo-adjuvant chemotherapy and/
or radiotherapy, and by related comorbidities, including osteoporosis
and history of smoking. Hence, superior sulcus tumors required both a
posterior incision over the spine and a posterolateral thoracotomy
[73,74]. The aforementioned papers by Moulding et al. first and Laufer
et al. later, reported higher rates of LC among patients treated with SRS
or SBRT, creating the basis for the idea of “hybrid therapy” in the
treatment of high grade MESCC due to radioresistant tumors, that could
not be considered candidates for “up-front” radiation treatment
[2,22,39]. The tumoricidal high doses of SRS or SBRT cannot be pro-
vided sparing the spinal cord if no space from the tumor was detected.
Hence, separation surgery should be the first step of the hybrid therapy
and has the paramount task to create this space (at least 2–3 mm)
providing safe targets for the second step that is represented by SRS or
SBRT [2,6,7,12,16,20–22,26,75].
Barzilai et al. described the technique in the thoracic spine in case of
ventral compression that consists in a first stabilizing step with the aim
Table 4
Consensus conturing guidelines for SBRT62.
Volume Include
Gross tumor volume (GTV) Postoperative residual based on MRI
Clinical tumor volume (CTV) Entire extent of preoperative tumor, anatomic compartment involved, & any postoperative residual
Surgical instrumentation & incision not included unless involved Prophylactic circumferential treatment of epidural space
controversial
Additional expansion up to 5 mm for paraspinal extension controversial
Consider an additional expansion of up to 5 mm cranio-caudally beyond known epidural disease extent based on pre- & postoperative
imaging
Planning target volume (PTV) 0- to 2-mm expansion from CTV
Spinal cord True spinal cord based on postoperative T2-weighted MRI or CT myelogram in cases of significant hardware artifact
Spinal cord planning risk volume (PRV) 0- to 2-mm expansion of spinal cord volume
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to restore/prevent spinal stability and obtain mechanical pain relief. All
patients that underwent circumferential separation surgery, indeed,
would require spinal instrumentation due to the tumor extension and to
the need of lamina and pedicle/joint removal in order to achieve ven-
tral decompression. Spinal instrumentation should be performed as the
first step to reduce the risk of spinal cord damage (Fig. 2). Long segment
fixation, that means 2 levels above and 2 levels below the tumor while
skipping the involved vertebra, was described [2]. Free hand or navi-
gated and open or percutaneous techniques could be adopted [75,76].
Moreover, considering the known need for subsequent radiation treat-
ment, carbon fiber/polyetheretherketone (PEEK) instrumentation has
been considered by other authors, in order to reduce scattering and
artifacts related to titanium implants [77–80]. The second step re-
presents the decompressive phase (Fig. 3). Due to the high grade
MESCC, one should avoid to transmit pressure to the spinal cord. In
order to obtain this, the bony structures should be thinned using the
high-speed drill and then removed with Kerrison rongeurs. A bilateral
corridor to the ventral aspect should be performed drilling the facet
joint and the pedicles. Thus, the ventral component of the tumor should
be carefully dissected away from the dura. About 20% of the involved
body should be removed to create a ventral cavity, then Hoffman li-
gaments and posterior longitudinal ligament (PLL) should be cut by
tenotomy scissors to detach the anterior side of the dura. Lastly, the
dissected epidural ventral tumor should be depressed anteriorly far
from the dura with Woodson dissector, obtaining circumferential se-
paration of the spinal cord [2,7,21,22]. Extended tumor removal inside
the vertebral body and/or into the paraspinal tissues should not be
required. However, poly-methyl-methacrylate (PMMA) insertion,
Fig. 2. Short posterior carbon fiber instrumentation ad separation surgery (D, E) in a case of high grade ESCC (A), due to lytic lung metastatic lesion of T8 (B, C).
Fig. 3. Clinical case (A-G): A, B) Pre-operative CT scan showing T9 MESCC (Bilsky grade: 2, SINS score: 12) from lung cancer, C) Circumferential separation surgery
was performed and D) intra-operative US assessing ventral separation of the spinal cord from the tumor is shown. E) Posterior carbon fiber instrumentation two level
above and below the pathological vertebra. F) Post-operative CT myelography showing restored CSF space around the cord. G) Post-operative CT scan revealing
screw instrumentation.
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Steinman pins using and PEEK/carbon fiber or non-expandable tita-
nium mesh cages could be adopted when more than than 50% of ver-
tebral body is removed [22]. Intra-operative neuromonitoring has been
largely suggested in order to prevent surgical related spinal cord da-
mage due to the high grade ESCC [2,81,82]. The aforementioned
principle surgical principles of circumferential separation could also be
applied – with different and specific approaches - for tumors involving
the cervical or lumbar spine [83–85].
Bate et al. published their results from a retrospective series of 57
patients with high grade MESCC treated with SRS alone or separation
surgery followed by adjuvant SRS. Of the 21 patients in separation
surgery plus SRS group, 9.5% rate of local failure was reported at 1-
year, while the regression analysis did not showed variables resulting to
be significant factors [66].
Recently, a prospective study including 111 patients by Barzilai
et al., reported results about QoL after “hybrid MESCC therapy”. Spine
pain severity at 3 months was significantly reduced and general activity
was also improved (p = 0.001); local recurrence rate resulted to be
2.1% and 4.3% at 6 months and 12 months, respectively. Moreover, re-
operated patients were associated with diminished patient reported
outcome improvement [39,86].
Many studies have also analyzed post-operative complications in
patients that underwent separation surgery. Wound healing and hard-
ware failure were the major concerns, considering both the need for
radiation therapy, the lack of anterior column reconstruction and the
low possibility to achieve bone fusion in cancer patients due to adjuvant
therapies and shorter life expectancy.
Drakhsandeh et al. reported no hardware failure in a retrospective
series of 27 patients undergoing posterior instrumentation without fu-
sion, while the more reliable 7-years retrospective experience by
Amankulor et al. that analyzing 318 patients treated with posterior
instrumentation without anterior column reconstruction reported 2.8%
of hardware failure incidence, while instrumentation longer than 6 le-
vels and chest wall resection resulted to be the risk factors for failure
[87–89]. Cofano et al. have recently reported no hardware failure in a
retrospective series of patients undergoing posterior carbon fiber /
PEEK instrumentation, with a mean follow up of 11 months [77].
About wound complications, a series of 140 patients by Wang et al.,
reported a wound complication rate of 10.6%, while in a review by
Bilsky et al., the different rate of wound infection or dehiscence be-
tween patients treated with cEBRT and SRS (17% vs 6%) was under-
lined [73,90].
5.2. Separation surgery – which is the role of Minimally Invasive
Techniques?
Minimal Access Spine (MAS) or Minimally Invasive Surgical (MIS)
techniques for the treatment of MESCC have gained increasingly in-
terest after the introduction of hybrid therapy and separation surgery,
according to their reported limited post-operative morbidity and their
related possibility for quick recovery and return to radiation and sys-
temic treatment [20,76,81,91]. Mini-open approaches, endoscopic or
percutaneous techniques and, lastly, ablative procedures have been
described [74,92–94]. In a review article by Pennington et al. the au-
thors reported shorter operative times, reduced blood loss, shorter re-
covery times and lower complications rate among patients treated with
MIS techniques. Moreover, other studies in the same review reported
similar results than open surgery regarding neurological outcomes [95].
Mini-open transpedicular corpectomy was described by Zhou et al, with
a midline facial incision over the corpectomy level of interest (in ad-
dition to percutaneous instrumentation above and below that level)
[92]. Additionally, Lau et al. compared patients who underwent mini-
open accesses to patients treated with standard open approaches re-
porting better results for the mini-open group as for blood loss and
length of hospitalization [96,97]. The use of tubular retractors for de-
compression purpose have been also analyzed among MIS techniques as
reported by Zuckerman et al [76].
Furthermore, endoscopic procedures have been described as MIS
technique. Cofano et al. reported promising results describing a series of
9 patients with thoracic MESCC undergoing 3D endoscopic transpedi-
cular route in order to achieve a safe ventral separation of the spinal
cord without the need for costotransversectomy, while thoracoscopy
resulted useful in patients with thoracic disease that required direct
anterior decompression [76,81].
Another evolution of focusing surgery to epidural decompression
was represented by spine Laser Interstitial Thermal Therapy (LITT)
[98–101]. Tatsui et al. have described an ablative percutaneous pro-
cedure able to reduce ESCC heating up the epidural component of the
tumor using laser under real time thermal MRI control. In their last
series of 19 patients no neurological injuries were reported, a mean
reduction of 22% of the median thickness of the epidural tumor was
observed at 2-months follow up (pre-procedure: 8 mm; follow up:
6.4 mm; p 0.012) and all patients underwent SRS with a median in-
terval of 3 days [99–101].
Hence, the need for less aggressive approach to obtain spinal cord
separation (e.g. mini open approaches), has led to consider MIS tech-
niques also for screws instrumentation, in order to reduce the fixation
related morbidities in these fragile patients [75]. Percutaneous screw
fixation could be considered, due to the limited muscles dissection and
tension band disruption with consequent lower reported blood loss,
decreased post-operative pain, earlier mobilization and more ex-
peditious time to radiation [75,76,102–104]. Moreover, short percu-
taneous instrumentations (only one level above and below the patho-
logical vertebra) could be performed with the aim to reduce both blood
loss and the risk of wound issues, since small incisions and limited sub-
fascial exposure were obtained both for fixation and for separation steps
[90]. Hence, in case of short instrumentations, cement augmentation of
the screws or of the anterior column could be an advantageous tool,
since it increase the screws’ purchase, decreasing the risk of hardware
failure due to osteoporotic bone or to subsequent radiotherapy [105].
Furthermore, cement augmentation of the anterior column (vertebro-
plasty or kiphoplasty) was associated with significative pain relief as
reported by Moussazadeh et al. [105–106].
Although MIS techniques have shown promising results, standard
open approaches are still the most widely used; hence, a careful se-
lection of patients considered suitable for MIS techniques should be the
rule [20,75].
5.3. Separation surgery – the role of imaging
The increasingly spread of separation surgery idea has led to focus
surgeon’s attention on the decompressive phase of surgery for MESCC,
shifting goal from the “oldest” extensive cytoreduction to the “newest”
separation. On the other hand, although an adequate separation is
crucial for safe ablative radiation delivery, there are no strong evidence
that define what adequate separation should mean. Barzilai et al, de-
scribing their surgical technique, reported that decompressive surgery
should guarantee at least 2–3 mm of separation from the spinal cord,
and this was confirmed in other paper by the same group, also con-
sidering the higher-dose constraints for the spinal cord and/or nerve
roots [2,15,22,64,107]. From this angle, an adequate intra and post-
operative separation assessment would be critic [105]. While posterior
and postero-lateral decompression could be easily evaluated, ventral
separation assessment could be critical. Hence, image guidance such as
navigation system or intra-operative ultra sound could be considered
the most reliable methods to visualize the ventral epidural space and
assess restoring of the ventral CSF space as reported by Vasudeva et al.
and Kelly at al. [22,107,108].
Post-operative assessment of circumferential free-space around the
spinal cord is also crucial for radiation planning. Because MRI-related
artifacts from hardware were considered a limit for correct radiation
planning, CT myelography has been described as the preferred exams to
G. Di Perna, et al. Journal of Bone Oncology 25 (2020) 100320
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better assess the separation [2,22]. Consensus contouring guidelines by
Redmond et al., indeed, indicated that the treatment should be planned
with co-registration of pre-operative and post-operative T1 weighted
MRI and spinal cord delineation on T2 weighted post-operative MRI or
CT myelography or in both [64].
6. Conclusion
The increasingly evidence of long-term LC obtained with SBRT and
the overcoming of radio-resistance have radically changed the surgical
management of MESCC, leading to the new concept of SS. The goal of
SS should be to separate the spinal cord from the tumor, providing a
safe target for SBRT or SRS. Because of the reduced life expectancy of
patients suffering from cancer, decreasing the morbidity of surgical
treatment is mandatory. From this perspective, the wide spectrum of
MIS techniques could represent a useful tool both for separation surgery
and instrumentation, in order to guarantee expeditious recovery and
prioritize the systemic treatment.
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